Remap

Consultancy specialising in pharma & life science pricing, reimbursement, health economics & market access

[Remap @Remapconsulting]

Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come https://t.co/GfE1DExGn7

[Remap @Remapconsulting]

CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push https://t.co/PetsxHBYFf

[Remap @Remapconsulting]

Pharmaceutical company AbbVie inflated prices for two major drugs, House Oversight report says https://t.co/Seveu3VMDi via @nbcnews #price #Pharmaceuticals

[Remap @Remapconsulting]

The top 20 drugs by worldwide sales in 2020 https://t.co/zHW1C4gVEz

[Remap @Remapconsulting]

NICE methods and process review aims to create fertile ground for innovation https://t.co/OCfPubBWYm via @pharmaphorum #price #Pharmaceutical

[Remap @Remapconsulting]

The Great Undoing: Which of Trump’s Policies Will Biden Reverse? https://t.co/ci4V8HcEwg via @khnews #price #Pharmaceutical #marketaccess

[Remap @Remapconsulting]

How will amazon entering the online pharmacy space in the EU and UK impact drug prices?
https://t.co/a2dHJyGx3I

[Life Sciences @LifeSciInsights]

The slight rebound in US drug price increases in January of 2021 signals a new era, although one likely fraught with new challenges for the industry: https://t.co/UXZoNbvBTd

[Remap @Remapconsulting]

#US #Hospitals Say They Will Publish Previously Secret #Prices. https://t.co/dsCfQpp6bn via @fwpharma

[Remap @Remapconsulting]

Drugmakers kick off 2021 with 500 U.S. #price hikes. https://t.co/X3wfe9pVhe via @fwpharma #launch

[Remap @Remapconsulting]

ICR calls for change to bring immunotherapies to more cancer patients. #pharma #marketaccess ://www.firstwordpharma.com/node/1767512 via @fwpharma

[Remap @Remapconsulting]

California may be the first state to develop its own generic drugs https://t.co/EXZu2kYMnL

[Remap @Remapconsulting]

As He Woos Drugmakers on Virus, Trump Demands Drug Price Controls https://t.co/9X2JMICgPc

[Remap @Remapconsulting]

Pharmaceutical industry signals it won’t extend irish #drugs deal. https://t.co/7sFJzgmJbL via @fwpharma

[Remap @Remapconsulting]

Moderna, Merck say they will not limit #price of #coronavirus #vaccines to company cost | NASDAQ https://t.co/MSLNsBLOGU

[Remap @Remapconsulting]

Trump signs series of executive orders aimed at lowering #drug costs https://t.co/3VYXCNP8dh #Pharmaceuticals #price

[Life Sciences @LifeSciInsights]

Drug prices rising and smaller markets hit particularly hard by supply chain disruption amid COVID-19 outbreaks. Read more:
https://t.co/ZLtrSx5QwD

[ICER @icer_review]

ICER Publishes White Paper on Alternative Policies for Drug and Vaccine Pricing During a Pandemic, Announces Cross-Stakeholder Discussion Series: https://t.co/KIGkXdpJdd

[Remap @Remapconsulting]

What's the hard cost of a pivotal #drug trial? A lot less than you might expect - https://t.co/2hJEnFvRyL

[Remap @Remapconsulting]

How #ICER Will Put Together Its 2020 Unsupported #Price Increase List https://t.co/3ZTa5RHLHK #Pharmaceutical #launch